Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Pfizer’s (NYSE: PFE) Ponsegromab Shows Promise in Fighting Cancer Cachexia
Singular Genomics (OMIC) Receives Buyout Offer, Stock Soars
Instil Bio (TIL) Surges on Promising Cancer Therapy Licensing Deal
Summit Therapeutics Secures $235 Million in Funding from Leading Biotech Investors
Monopar Therapeutics’ (MNPR) MNPR-101-Zr Shows Promising Tumor Targeting in Early Clinical…
Finance
Aligos Therapeutics ($ALGS): A Bold Move to Regain Nasdaq Compliance
Portage Biotech Inc. (NASDAQ: PRTG): A Closer Look at a Tumultuous…
Avalon GloboCare (ALBT) surges post Launch of Innovative Male Incontinence Device
Reason why Inspirato Incorporated (ISPO) has high trading volume today
Clearmind Medicine Inc (CMND) briefly surges and here’s why
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Biotech
Page 338
Biotech
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pfizer’s (NYSE: PFE) Ponsegromab Shows Promise in Fighting Cancer Cachexia
Gavins Felicity
-
September 15, 2024
Singular Genomics (OMIC) Receives Buyout Offer, Stock Soars
Instil Bio (TIL) Surges on Promising Cancer Therapy Licensing Deal
Summit Therapeutics Secures $235 Million in Funding from Leading Biotech Investors
Monopar Therapeutics’ (MNPR) MNPR-101-Zr Shows Promising Tumor Targeting in Early Clinical Trial
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Releases Positive Third Phase BOSTON Study Data...
Gavins Felicity
-
June 3, 2020
0
Cerecor Inc. (NASDAQ:CERC) Receives IND Approval From The FDA For CERC-002...
Kate Hudson
-
June 3, 2020
0
NantKwest Inc. (NASDAQ:NK) and ImmunityBio Collaborate In Development of Adenovirus COVID-19...
Matt Wade
-
June 3, 2020
0
VistaGen Therapeutics (NASDAQ:VTGN) Sign Agreement With Nuformix To Develop AV-101 cocrystalline...
Kate Hudson
-
June 3, 2020
0
Aileron Therapeutics (NASDAQ:ALRN) Initiates Cohort Expansion and Enroll First Patient In...
Gavins Felicity
-
June 3, 2020
0
1
...
337
338
339
...
346
Page 338 of 346
Recent Post
Pfizer’s (NYSE: PFE) Ponsegromab Shows Promise in Fighting Cancer Cachexia
Gavins Felicity
-
September 15, 2024
0
Pfizer (NYSE: PFE) recently announced positive results from a midstage trial of their experimental drug, ponsegromab, designed to treat cancer cachexia, a...
Singular Genomics (OMIC) Receives Buyout Offer, Stock Soars
September 15, 2024
Instil Bio (TIL) Surges on Promising Cancer Therapy Licensing Deal
September 12, 2024
Summit Therapeutics Secures $235 Million in Funding from Leading Biotech Investors
September 12, 2024
Monopar Therapeutics’ (MNPR) MNPR-101-Zr Shows Promising Tumor Targeting in Early Clinical...
September 12, 2024